Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A1 | P53985 | 18/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | PDE2A | O00408 | 1/20 | 0.36 |
| ▸ | PDE1A | P54750 | 1/20 | 0.36 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.36 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5864728 | 0.89 | POLB (0.43) | SLC16A1POLBCYP2C9 | |
| SCHEMBL7004534 | 0.87 | PDE1A (0.41) | SLC16A1CYP2C9PDE2APDE1APDE1B | |
| SCHEMBL5865248 | 0.86 | PDE1A (0.41) | SLC16A1CYP2C9PDE2APDE1APDE1B | |
| SCHEMBL5865253 | 0.83 | PARG (0.37) | SLC16A1POLBCYP2C9PDE2APDE1A | |
| SCHEMBL5864724 | 0.82 | LMNA (0.42) | SLC16A1POLBCYP2C9PDE2APDE1A | |
| SCHEMBL5864761 | 0.81 | SLC16A1 (0.42) | SLC16A1CYP2C9 | |
| SCHEMBL7009336 | 0.81 | PDE1A (0.38) | SLC16A1CYP2C9PDE2APDE1APDE1B | |
| SCHEMBL7007349 | 0.80 | PDE1A (0.38) | SLC16A1CYP2C9PDE2APDE1APDE1B | |
| SCHEMBL7009074 | 0.79 | TSHR (0.39) | SLC16A1CYP2C9PDE2APDE1APDE1B | |
| SCHEMBL7006740 | 0.78 | PDE1A (0.38) | SLC16A1CYP2C9PDE2APDE1APDE1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6984644-B2 | Treatment of skin disorders using thieno[2,3-D]pyrimidinediones | ASTRAZENECA AB (SE) | 2006-01-10 | — | — | US | claimed |
| US-6469014-B1 | IMMUNOSUPPRESSIVE ACTIVITY | ASTRAZENECA AB (SE) | 2002-10-22 | — | — | US | claimed |
| EP-0991653-B1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2002-10-16 | — | — | EP | claimed |
| US-6984644-B2 | Treatment of skin disorders using thieno[2,3-D]pyrimidinediones | ASTRAZENECA AB (SE) | 2006-01-10 | — | — | US | disclosed |
| US-6469014-B1 | IMMUNOSUPPRESSIVE ACTIVITY | ASTRAZENECA AB (SE) | 2002-10-22 | — | — | US | disclosed |